Delivery Order SPE2DB22D2214-SPE2DB24FS4PN
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $3,697.45 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on May 19, 2023, with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,257.96 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of September 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,610.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,612.34 for Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of January 8, 2024 and uses a firm fixed price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,963.13 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award, valued at $13,472.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent organization Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $8,824.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 22, 2023. This contract is a delivery order and has a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.08 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. This contract is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $30,768.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens in 1.5 mL quantities, with a completion date of March 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml volume. The Firm Fixed Price contract, valued at $14,519.97, has an ultimate completion date of August 29, 2023. This is a Delivery Order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4PNDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,302.32, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor and healthcare solutions provider, plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/26/24 |